GGrantIndex
← Leaderboards

Wonkyu Ju

University Of California, San Diego

$7,383,492
Attributed
$11,881,599
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.4M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,881,599 · 6

By mechanism

R01$10,546,517 · 4
UG3$835,082 · 1
R41$500,000 · 1

Top collaborators

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Nerve Degeneration

Research focus

Nerve DegenerationMitochondrial DysfunctionMitochondriaCell DeathProteinsCell SurvivalBioenergeticsLinkGlaucomaRetinal Ganglion CellsRetinaPhysiologic Intraocular PressureMediatingAxonOptic Nerve DisorderCellsFunctional DisorderRespirationBlindnessPrimary Open Angle GlaucomaGenesVisionSynapsesMouse Model

Grant awards (30)

Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's Disease$753,317
R01 · FY2025 · AG
AIBP-mediated neuroprotection in glaucomatous optic neuropathy$622,812
R01 · FY2025 · EY · contact PI
AIBP-mediated neuroprotection in glaucomatous optic neuropathy$54,055
R01 · FY2025 · EY · contact PI
Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's Disease$781,587
R01 · FY2024 · AG
AIBP-mediated neuroprotection in glaucomatous optic neuropathy$626,352
R01 · FY2024 · EY · contact PI
Development of AAV-AIBP for neuroprotection in glaucoma$58,300
UG3 · FY2024 · NS · contact PI
AIBP-mediated neuroprotection in glaucomatous optic neuropathy$43,028
R01 · FY2024 · EY · contact PI
Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's Disease$789,121
R01 · FY2023 · AG
Development of AAV-AIBP for neuroprotection in glaucoma$776,782
UG3 · FY2023 · NS · contact PI
AIBP-mediated neuroprotection in glaucomatous optic neuropathy$644,896
R01 · FY2023 · EY · contact PI
Mitochondrial Protection in Glaucomatous Optic Neuropathy$499,975
R01 · FY2023 · EY · contact PI
Mitochondrial Protection in Glaucomatous Optic Neuropathy$394,991
R01 · FY2023 · EY · contact PI
AAV-AIBP Therapy for Alzheimer's Disease$252,944
R41 · FY2023 · AG · contact PI
Mitochondrial Protection in Glaucomatous Optic Neuropathy$484,977
R01 · FY2022 · EY · contact PI
Mitochondrial Protection in Glaucomatous Optic Neuropathy$259,676
R01 · FY2022 · EY · contact PI
AAV-AIBP Therapy for Alzheimer's Disease$247,056
R41 · FY2022 · AG · contact PI
Mitochondrial Protection in Glaucomatous Optic Neuropathy$489,907
R01 · FY2021 · EY · contact PI
Mitochondrial Protection in Glaucomatous Optic Neuropathy$109,288
R01 · FY2021 · EY · contact PI
Mitochondrial Protection in Glaucomatous Optic Neuropathy$503,843
R01 · FY2020 · EY · contact PI
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy$387,500
R01 · FY2017 · EY · contact PI
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy$32,400
R01 · FY2017 · EY · contact PI
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy$387,500
R01 · FY2016 · EY · contact PI
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy$379,750
R01 · FY2015 · EY · contact PI
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy$39,400
R01 · FY2015 · EY · contact PI
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy$379,750
R01 · FY2014 · EY · contact PI
Mitochondrial Dysfunction in Glaucomatous Optic Neuropathy$387,500
R01 · FY2013 · EY · contact PI
Mitochondrial dysfunction in glaucomatous optic neuropathy$367,092
R01 · FY2012 · EY · contact PI
Mitochondrial dysfunction in glaucomatous optic neuropathy$367,092
R01 · FY2011 · EY · contact PI
Mitochondrial dysfunction in glaucomatous optic neuropathy$382,388
R01 · FY2010 · EY · contact PI
Mitochondrial dysfunction in glaucomatous optic neuropathy$378,320
R01 · FY2009 · EY · contact PI